ATE454890T1 - Verfahren zur herstellung hochreines amlodipinbenzolsulfonat - Google Patents

Verfahren zur herstellung hochreines amlodipinbenzolsulfonat

Info

Publication number
ATE454890T1
ATE454890T1 AT02765135T AT02765135T ATE454890T1 AT E454890 T1 ATE454890 T1 AT E454890T1 AT 02765135 T AT02765135 T AT 02765135T AT 02765135 T AT02765135 T AT 02765135T AT E454890 T1 ATE454890 T1 AT E454890T1
Authority
AT
Austria
Prior art keywords
methyl
high purity
benzene sulfonate
producing high
chlorophenyl
Prior art date
Application number
AT02765135T
Other languages
English (en)
Inventor
Borut Furlan
Marijan Resnik
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE454890T1 publication Critical patent/ATE454890T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02765135T 2001-07-06 2002-07-05 Verfahren zur herstellung hochreines amlodipinbenzolsulfonat ATE454890T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200100479 2001-07-06
PCT/IB2002/002668 WO2003004025A1 (en) 2001-07-06 2002-07-05 High purity amlodipine benzenesulfonate and a process for its preparation

Publications (1)

Publication Number Publication Date
ATE454890T1 true ATE454890T1 (de) 2010-01-15

Family

ID=20433024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02765135T ATE454890T1 (de) 2001-07-06 2002-07-05 Verfahren zur herstellung hochreines amlodipinbenzolsulfonat

Country Status (5)

Country Link
US (1) US7153970B2 (de)
EP (1) EP1435954B1 (de)
AT (1) ATE454890T1 (de)
DE (1) DE60235101D1 (de)
WO (1) WO2003004025A1 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US5389654A (en) * 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
UA72768C2 (en) * 1999-07-05 2005-04-15 Richter Gedeon Vegyeszet A method for obtaining amilodipine benzenesulphonate
GB0020842D0 (en) * 2000-08-23 2000-10-11 Pfizer Ltd Therapeutic compositions

Also Published As

Publication number Publication date
DE60235101D1 (de) 2010-03-04
EP1435954A1 (de) 2004-07-14
US7153970B2 (en) 2006-12-26
US20040176606A1 (en) 2004-09-09
EP1435954B1 (de) 2010-01-13
WO2003004025A8 (en) 2004-10-21
WO2003004025A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
EP0071819B1 (de) Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
US4430333A (en) Dihydropyridine anti-ischaemic and antihypertensive agents
IL34304A (en) Process for the production of n-substituted 1,4-dihydro-3,5-pyridine dicarboxyylic acid esters
KR870002073A (ko) 헤테로 사이클릭 유도체의 제조방법
SI9200344B (sl) Postopek za pripravo amlodipin benzensulfonata
RU93052391A (ru) Способ получения амлодипинбензолсульфоната и промежуточное для него
Reddy et al. Chemical and pharmacological significance of 1, 4-dihydropyridines
ATE283841T1 (de) Verfahren zur herstellung von amlodipin- benzolsulfonat
KR100488384B1 (ko) 신규한제조방법
RU2069658C1 (ru) Способ получения энантиомерно чистых 1,4-дигидропиридинов, энантиомерно чистые 1,4-дигидропиридины и изотиоуреиды
ATE454890T1 (de) Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
EP0215250B1 (de) 2-Substituierte-1,4-dihydropyridine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK233686A (da) Fremgangsmaade til fremstilling af 2-(n-benzyl-n-methylamino)-ethylmethyl-2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydro-pyridin-3,5-dicarboxylat eller hydrochloridet deraf
McInally et al. A novel, base-induced fragmentation of hantzsch-type 4-aryl-1, 4-dihydropyridines
NO167029B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
EP1368315B1 (de) Verfahren zur herstellung von amlodipin
KR870000299A (ko) 1,4-디히드로피리딘 유도체의 제조방법
WO2003099790A1 (en) Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
JPH0641063A (ja) ピロリジン誘導体
NO842092L (no) Fremgangsmaate for fremstilling av 2,6-disubstituerte-1,4-dihydropyridin-derivater
YU47901A (sh) Amlodipin benzensulfonat visoke čistoće i postupak za njegovo dobijanje
JPS6330304B2 (de)
RU2161156C1 (ru) Способ получения 3-этил-5-метиловый эфир 2-[2-(n-фталимидо)-этоксиметил]-4-(2-хлорфенил)-1,4-дигидро-6-метил-3,5- пиридиндикарбоновой кислоты
JPH04211080A (ja) 新規ジヒドロピリジン誘導体、その製法および用途
KR870002135A (ko) 광학적 활성, 치환된 1,4-디히드로피리딘의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties